Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-19T02:03:47.629Z Has data issue: false hasContentIssue false
  • English
  • Français

Hospital-based Psychiatric Service Utilization and Morbidity in Multiple Sclerosis

Published online by Cambridge University Press:  18 September 2015

John D. Fisk ,
Susan A. Morehouse ,
Murray G. Brown ,
Chris Skedgel  and
T. Jock Murray
John D. Fisk*
Affiliation:
Department of Psychology, Queen Elizabeth Il Health Sciences Centre, Dalhousie University, Halifax. Department of Psychiatry, Dalhousie University, Halifax. Department of Medicine, Dalhousie University, Halifax. Department of Psychology, Dalhousie University, Halifax.
Susan A. Morehouse
Affiliation:
Department of Psychology, Dalhousie University, Halifax.
Murray G. Brown
Affiliation:
Department of Community Health and Epidemiology, Dalhousie University, Halifax.
Chris Skedgel
Affiliation:
Department of Community Health and Epidemiology, Dalhousie University, Halifax.
T. Jock Murray
Affiliation:
Department of Medicine, Dalhousie University, Halifax.
*
Queen Elizabeth Il Health Sciences Centre, Department of Psychology, Abbie Lane Building, 5909 Jubilee Street, Halifax, Nova Scotia, Canada B3H 2E2
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Despite the common association of psychiatric morbidity and multiple sclerosis (MS), population-based prevalence estimates of these disorders are limited. Such estimates are of particular importance to those conducting trials of interventions for the treatment of MS. This study examined the prevalence of bipolar disorder, depression, and attempted suicide among hospital service utilizers in Nova Scotia and compared these measures for the MS and non-MS population.

Methods:

Data regarding diagnosis and utilization were extracted from two linked databases which included all hospital separation records for Nova Scotia over a 3 year period (1992/93-1994/95).

Results:

The prevalence of bipolar disorder in hospitalized MS patients was 1.97% and depression was 4.27%. These rates were significantly higher than the 0.92% and 2.04%, respectively, for the non-MS hospital utilizers. These diagnoses also accounted for more than half of the primary diagnostic codes for psychiatric service separations by MS patients. The proportion of total hospital utilization which was accounted for by psychiatric services did not differ between MS and non-MS utilizers. While suicide attempts were rare, the estimated frequency of suicide attempts in the total MS population was more than three times that of the general population.

Conclusions:

Bipolar disorder and depression were twice as prevalent in hospitalized MS patients as in the general population of hospital utilizers while the estimated frequency of suicide attempts was at least three times greater. These results illustrate that psychiatric morbidity and service utilization are important considerations in the care of MS patients.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 25 , Issue 3 , August 1998 , pp. 230 - 235
Copyright
Copyright © Canadian Neurological Sciences Federation 1998

References

REFERENCES

1.Patterson, MB, Foliart, R. Multiple Sclerosis: understanding the psychologic implications. Gen Hosp Psychiatr 1985; 7: 234–238.CrossRefGoogle ScholarPubMed
2.Murray, TJ. The psychosocial aspects of multiple sclerosis. Neurol Clin 1995; 13: 197–223.CrossRefGoogle ScholarPubMed
3.Rabins, PV. Euphoria in multiple sclerosis. In: Rao, S, ed. Neurobehavioral Aspects of Multiple Sclerosis. New York: Oxford University Press, 1990: 180–186.Google Scholar
4.Joffe, RT, Lippert, GP, Gray, TA, Sawa, G, Horvath, Z. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376–378.CrossRefGoogle ScholarPubMed
5.Schiffer, RB, Wineman, NM, Weitkamp, LR. Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatr 1986; 143: 94–95.Google ScholarPubMed
6.Minden, SL, Orav, J, Reich, P. Depression in multiple sclerosis. Gen Hosp Psychiatr 1987; 9: 426–434.CrossRefGoogle ScholarPubMed
7.Schiffer, RB, Caine, ED, Bamford, KA, Levy, S. Depressive episodes in patients with multiple sclerosis. Am J Psychiatr 1983; 140: 1498–1500.Google ScholarPubMed
8.Schiffer, RB. The spectrum of depression in multiple sclerosis: an approach for clinical management. Arch Neurol 1987; 44: 596–599.CrossRefGoogle ScholarPubMed
9.Sullivan, MJL, Weinshenker, B, Mikail, S, Edgley, K. Depression before and after diagnosis of multiple sclerosis. Mult Scler 1995; 1: 104–108.CrossRefGoogle ScholarPubMed
10.Whitlock, FA, Siskind, MM. Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43: 861–865.CrossRefGoogle Scholar
11.Schiffer, RB, Babigan, HM. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: an epidemiologic study. Arch Neurol 1984; 41: 1067–1069.CrossRefGoogle ScholarPubMed
12.Minden, SL, Schiffer, RB. Depression and mood disorders in multiple sclerosis. Neuropsychiatr Neuropsychol Behav Neurol 1991; 4: 62–77.Google Scholar
13.Ron, MA, Logsdail, SJ. Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med 1989; 19: 887–895.CrossRefGoogle ScholarPubMed
14.Schiffer, RB. Disturbances of affect. In: Rao, S, ed. Neurobehavioral Aspects of Multiple Sclerosis. New York: Oxford University Press, 1990: 186–196.Google Scholar
15.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. 1987 Washington, DC: American Psychiatric Association Press.Google Scholar
16.Arias, B, Vazquez-Barquero, JL, Pena, C, Miro, J, Berciano, JA. Psychiatric aspects of multiple sclerosis. Acta Psychiat Scand 1991; 83: 292–295.Google Scholar
17.Millefiorini, E, Padovani, A, Pozzili, C, et al. Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities. Acta Neurol Scand 1992; 86: 354–358.CrossRefGoogle ScholarPubMed
18.Dalos, NP, Rabins, PV, Brooks, BR, O’Donnell, P. Disease activity and emotional state in multiple sclerosis. Ann Neurol 1983; 13: 573–577.CrossRefGoogle Scholar
19.Stenager, EN, Stenager, E, Koch-Henriksen, N, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992; 55: 542–545.CrossRefGoogle ScholarPubMed
20.Sadovnick, AD, Eisen, K, Ebers, GC, Paty, DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193–1196.CrossRefGoogle ScholarPubMed
21.Eklund, V, Macdonald, ML. Descriptions of persons with multiple sclerosis, with an emphasis on what is needed from psychologists. Prof Psychol Res Pract 1991; 22: 277–284.CrossRefGoogle Scholar
22.Skegg, K. Multiple sclerosis presenting as a pure psychiatric disorder. Psychol Med 1993; 23: 909–914.CrossRefGoogle ScholarPubMed
23.Pine, DS, Douglas, CJ, Charles, E, Davies, M, Kahn, D. Patients with multiple sclerosis presenting to psychiatric hospitals. J Clin Psychiatr 1995; 56: 297–308.Google ScholarPubMed
24.The IFNB Multiple Sclerosis Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43: 655–661.CrossRefGoogle Scholar
25.Bauer, HJ, Hanefeld, FA. Multiple sclerosis: its impact from childhood to old age. London: WB Saunders Company, 1993.Google Scholar
26.Devins, GM, Seland, TP. Emotional impact of multiple sclerosis: recent findings and suggestion for future research. Psychol Bull 1987; 101: 363–375.CrossRefGoogle ScholarPubMed
27.Minden, SL, Schiffer, RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990; 47: 98–104.CrossRefGoogle ScholarPubMed
28.Stenager, E, Jensen, K. Multiple sclerosis: correlation of psychiatric admissions to onset of initial symptoms. Acta Neurol Scand 1988; 77: 414–417.CrossRefGoogle ScholarPubMed
29.The Educational Annotation of the International Classification of Diseases, 9th revision, Clinical Modification, 4th Edition. Reno, Nevada: Channel Publishing Ltd, 1995.Google Scholar
30.Poser, CM, Pary, DW, Scheinberg, L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.CrossRefGoogle ScholarPubMed
31.Pryse-Phillips, WEM. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984. Ann Neurol 1986; 20: 323–328.Google Scholar
32.Hader, WJ, Elliot, M, Ebers, GC. Epidemiology of multiple sclerosis in London, and Middlesex County, Ontario, Canada. Neurology 1988; 38: 617–621.CrossRefGoogle ScholarPubMed
33.Sadovnick, AD, Eisen, K, Egers, GC, Paty, DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41: 1193–1196.CrossRefGoogle ScholarPubMed
34.Warren, S, Warren, KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993; 43: 1760–1763.CrossRefGoogle ScholarPubMed
35.Wynn, DR, Rodriguez, M, O’Fallon, WM, Kurland, LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990; 40: 780–786.CrossRefGoogle ScholarPubMed
36.Brown, MG, Murray, TJ, Fisk, JD, et al. A therapeutic and economic analysis of Betaseron in multiple sclerosis. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCHOTA), 1996.Google Scholar
37.Neilley, LK, Goodin, DS, Goodkin, DE, Hauser, SL. Side effect profile of interferon beta-lb in MS: results of an open label trial. Neurology 1996; 46: 552–554.CrossRefGoogle Scholar
38.Mohr, DC, Goodkin, DE, Likosky, W, et al. Treatment of depression improves adherence to interferon beta-lb therapy for multiple sclerosis. Arch Neurol 1997; 54: 531–538.CrossRefGoogle Scholar